Get the full Grit Biotechnology company profile
Access contacts, investors, buying signals & more
With its lead tumor-infiltrating lymphocyte (TIL) therapy already in Phase 1 clinical trials, Chinese cell therapy company Grit Biotechnology has now secured $1.2M in seed funding.
Founded in 2019, Grit Bio is developing treatments for solid tumors, notably with GT101, its non-gene-modified TIL product. GT101 was the first TIL product to receive Investigational New Drug (IND) approval in China, leveraging the company's proprietary StaViral®, ImmuT Finder®, and StemTexp® technology platforms.
Sonosemi Medical
Sonosemi Medical Founded in April 2020 and headquartered in Shenzhen, China's hub of technological innovation, Sonosemi Medical is a National High-Tech Enterprise dedicated to pioneering active vascular interventional diagnosis and treatment solutions. As a leading provider and trailblazer in this field in China, we are committed to delivering greener, more precise, and safer medical solutions, driven by cutting-edge technology and unmet clinical needs. Through our dual-drive approach—integrating clinical insights with technological innovation—Sonosemi Medical combines relentless R&D expertise with an integrated "R&D-Production-Commercialization" strategy and open collaboration. We have successfully launched groundbreaking products, including: Coronary Intravascular Lithotripsy System, Intracardiac Echocardiography System, Peripheral Intravascular Lithotripsy System, etc. By building a comprehensive portfolio of vascular interventional solutions, we strive to address full-scenario clinical demands and create exceptional value for healthcare providers and patients worldwide.
$100.0M Series b
3 days ago
Pinduoduo
Pinduoduo is a mobile-only marketplace that connects millions of agricultural producers with consumers across China. Pinduoduo aims to bring more businesses and people into the digital economy so that local communities can benefit from the increased productivity and convenience through new market opportunities.
Largest funding rounds in Biotechnology on Signalbase right now.
| # | Company | Round | Amount | Date |
|---|---|---|---|---|
| 1 |  Shockwave Medical United States | Unknown | $13.1B | 1y ago |
| 2 |  NeuroEM Therapeutics United States | Unknown |
Companies that recently closed a Seed round.
| # | Company | Round | Amount | Date |
|---|---|---|---|---|
| 1 |  Auben Networks United States | Seed | $1.4M | today |
| 2 |  NEXUS AI Canada | Seed | $1.3M | today |
| 3 |
$5.0B Unknown
5 days ago
| $7.2B |
| 1y ago |
| 3 |  GRAIL United States | Unknown | $7.1B | 1y ago |
| 4 |  Illumina United States | Unknown | $7.1B | 1y ago |
| 5 |  RemeGen Biosciences United States | Grant | $5.6B | 6mo ago |
 Terra Robotics Greece |
| Seed |
| $3.1M |
| today |
| 4 | .png&w=3840&q=75) Piche Resources (ASX:PR2) Australia | Seed | $4.5M | today |
| 5 |  Furbnow United Kingdom | Seed | $3.3M | today |
Contacts, investors, buying intent signals & tech stack.
Trusted by 200+ sales teams
See who invested in Grit Biotechnology and reach their contacts directly.
Start free trialUnlock 6 more key decision-makers at Grit Biotechnology with verified emails and LinkedIn.
Start free trial
Active Global Specialised Caregivers
Recently received
Brano Therapeutics
Recently received
Diametos GmbH
Recently received
